Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

NCT00057447 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped administrative reasons

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Interferon Gamma-1b
DRUG: Rituximab

Sponsor

InterMune